Home
Great Ormond Street Hospital is one of the world’s leading children’s hospitals.
Since 1852 we’ve had the privilege of working to discover better, kinder treatments for the rarest and most complex illnesses to help children reach their full potential.
GOSH in numbers
750
patients seen each day
Every day seriously ill children and young people are seen at GOSH for life-changing treatment and care
212
active clinical trials
Transformational clinical trials are currently happening throughout the hospital
18,605
learning opportunities delivered
GOSH Learning Academy provides multi-professional paediatric healthcare education and training
GOSH news
From staff idea to global innovation: Taking the next step towards improving patient safety
7 Sep 2026, 2:59 p.m.
A simple idea developed by a GOSH clinician has secured a commercial partner.
Read more
Four research projects receive funding to improve understanding and treatment of childhood cancer
4 Sep 2026, 11:40 a.m.
Researchers at Great Ormond Street Hospital (GOSH) and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have received funding from The Little Princess Trust for four childhood cancer research projects.
Read more
New study brings hope for children with rare life-threatening kidney disease
27 Aug 2026, 9:19 a.m.
New research funded by Great Ormond Street Hospital Charity (GOSH Charity), LifeArc and Kidney Research UK has taken an important step towards developing a new treatment for serious genetic kidney diseases affecting children.
Read more
Building the next generation of paediatric research leaders
17 Aug 2026, 3:32 p.m.
From early career clinicians to emerging scientists, the NIHR GOSH Biomedical Research Centre (BRC)’s Academic Training Weekend is shaping the future of paediatric research - bringing together talent, expertise and ambition from across the UK.
Read more
Bagri family philanthropy enables UCL study into rare childhood neurological condition treated at GOSH
11 Aug 2026, 3:14 p.m.
A generous donation from the Bagri family will underpin a landmark study into gene-editing treatments for Dihydropteridine reductase deficiency (DHPR deficiency), an ultra-rare childhood neurological condition, treated at GOSH
Read more
Creating communities and lasting involvement
6 Aug 2026, 1 p.m.
At GOSH, patient and public involvement and engagement (PPIE) builds lasting relationships and communities that shape research over time.
Read more